Consensus statement—graft treatment in cardiovascular bypass graft surgery
Coronary artery bypass grafting (CABG) is and continues to be the preferred revascularization strategy in patients with multivessel disease. Graft selection has been shown to influence the outcomes following CABG. During the last almost 60 years saphenous vein grafts (SVG) together with the internal...
Main Authors: | Maximilian Y. Emmert, Johannes Bonatti, Etem Caliskan, Mario Gaudino, Martin Grabenwöger, Martin T. Grapow, Paul Phillip Heinisch, Teresa Kieser-Prieur, Ki-Bong Kim, Attila Kiss, Fatima Mouriquhe, Markus Mach, Adrianna Margariti, John Pepper, Louis P. Perrault, Bruno K. Podesser, John Puskas, David P. Taggart, Om P. Yadava, Bernhard Winkler |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1285685/full |
Similar Items
-
Graft preservation confers myocardial protection during coronary artery bypass grafting
by: Philipp Szalkiewicz, et al.
Published: (2022-07-01) -
Small-diameter bacterial cellulose-based vascular grafts for coronary artery bypass grafting in a pig model
by: Deborah Fusco, et al.
Published: (2022-09-01) -
Impact of CytoSorb® on interleukin-6 in cardiac surgery
by: Daniela Geisler, et al.
Published: (2023-08-01) -
Specific Graft Treatment Solution Enhances Vascular Endothelial Function
by: Attila Kiss, et al.
Published: (2022-10-01) -
Preservation solutions to improve graft patency: The devil is in the detail
by: Etem Caliskan, et al.
Published: (2020-08-01)